您好,欢迎访问浙江省农业科学院 机构知识库!

The mitigative effect of isorhamnetin against type 2 diabetes via gut microbiota regulation in mice

文献类型: 外文期刊

作者: Li, Jinjun 1 ; Yuan, Huimin 2 ; Zhao, Zhiqi 1 ; Li, Li 6 ; Li, Xiaoqiong 1 ; Zhu, Liying 4 ; Wang, Xin 1 ; Sun, Ping 4 ; Xiao, Yinping 1 ;

作者机构: 1.Zhejiang Acad Agr Sci, State Key Lab Managing Biot & Chem Threats Qual &, Hangzhou, Peoples R China

2.Zhejiang Acad Agr Sci, Inst Food Sci, Hangzhou, Peoples R China

3.Minist Agr & Rural Affairs, Key Lab Postharvest Preservat & Proc Vegetables Co, Hangzhou, Peoples R China

4.Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Peoples R China

5.Shanxi Med Univ, Sch Basic Med Sci, Dept Pharmacol, Taiyuan, Peoples R China

6.Hangzhou Normal Univ, Clin Med Coll, Hangzhou, Peoples R China

关键词: isorhamnetin; type 2 diabetes; fasting blood glucose; gut microbiota; lipid metabolism

期刊名称:FRONTIERS IN NUTRITION ( 影响因子:6.59; 五年影响因子:6.873 )

ISSN: 2296-861X

年卷期: 2022 年 9 卷

页码:

收录情况: SCI

摘要: In order to demonstrate the effects of isorhamnetin (IH) on the symptoms of type 2 diabetes mellitus (T2DM) and the role of gut microbiota in this process, an T2DM mouse model was established via a high-fat diet and streptozotocin. After 6 weeks of IH intervention and diabetes phenotype monitoring, the mice were dissected. We detected blood indicators and visceral pathology. Contents of the cecum were collected for 16S rRNA sequencing and short chain fatty acid (SCFAs) detection. The results showed that after IH intervention, the body weight of type 2 diabetic mice was gradually stabilized, fasting blood glucose was significantly decreased, and food intake was reduced (P < 0.05). Isorhamnetin significantly increased the level of SCFAs and decreased the levels of blood lipids and inflammatory factors in mice (P < 0.05). 16S rRNA sequencing results showed that Lactobacillus were significantly decreased and Bacteroidales S24-7 group_norank were significantly increased (P < 0.05). Interestingly, gut microbiota was significantly correlated with inflammatory factors, blood lipids, and SCFAs (P < 0.05). Taken together, our data demonstrated that isorhamnetin could improve the diabetic effects in T2DM mice, which might be mediated by gut microbiota.

  • 相关文献
作者其他论文 更多>>